Next week’s WONCA global conference in Sydney is an important event for GPs Worldwide to gather and share knowledge, particularly regarding primary care practices in different countries, and to address challenges in workforce and funding in healthcare systems.
Over 3000 delegates from around the World will gather at the 50th celebration of WONCA to reconnect and revive General Practice, sharing knowledge and learnings on access, equity, funding, and multidisciplinary care teams. This includes networking with Australian and overseas GPs and in particular learning about primary care practices in other countries.
The WONCA 2023 World Conference in Sydney is hosted by The Royal Australian College of General Practitioners (RACGP) . RACGP is the voice of general practitioners (GPs) across cities and throughout rural and remote Australia. For more than 60 years, the organisation has supported the backbone of Australia’s health system by setting the standards for education and practice and advocating for better health and wellbeing for all Australians.
Australian Health Journal met with Dr Nicole Higgins, President of RACGP in transit at Brisbane Airport recently and she spoke about the $6 Billion allocated in the Federal Budget in May as a significant achievement for General Practice investment. She also emphasised this announcement reinforced GPs should be at the centre of multidisciplinary care teams to ensure continuity of care and better health outcomes.
Dr Higgins also spoke about the new Commonwealth Government led Scope of Practice review being crucial for General Practice to address the challenges of workforce and funding in the primary healthcare system.
Dr Higgins describes WONCA as the FIFA World Cup of General Practice! And that Australian doctors are excited about the upcoming WONCA conference being held at the Sydney ICC between the 26th to 29th of October. The same conference will include GP23 as the RACGP yearly gathering of Australian GPs.
About WONCA
WONCA is an acronym comprising of the first five initials of the World Organisation of National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians. WONCA’s short name is World Organisation of Family Doctors. It is a not-for-profit organisation with 132 member organisations in 110 countries and territories, with membership of around 500,000.
WONCA represents and advocates for its constituent members at an international level where it interacts with world bodies such as the World Health Organization (WHO).
-
Metabolic health expert talks about healthy ageing
David Beard is a highly experienced Exercise Physiologist with a specialisation in metabolic health and healthy aging. He has spent over 40 years in this profession, even before exercise physiology was formally recognised as a discipline. His extensive background includes over a decade of working in aged care and a strong focus on adult health and fitness. David has authored a book on healthy aging and dedicated the last 10 to 12 years to advancing his expertise in metabolic health issues such as diabetes, weight loss, and inflammatory conditions. He is a co-owner of HFRC in Nedlands, Western Australia, where he has worked for nearly a decade.
-
Family biz succeeds in vaccine approval & distribution
It’s been 10 years since Jenny and Karl Herz started in business. Over the past 10 years they’ve launched Biointelect and Biocelect businesses to help secure approval and distribution for new medicines into Australia.
In this Australian Health Journal interview, Jenny and Karl talk about the journey the husband and wife team took to get the Novavax COVID-19 vaccine (Nuvaxovid) approved and distributed in Australia. The journey didn’t just include talented and diverse skilled staff but also their children working in both organisations.
-
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
